Verifying…
Home / Drug A–Z / Amoxicillin Powder for Oral Suspension

Amoxicillin Powder for Oral Suspension

NAFDAC Reg. No. A4-3738 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Amoxicillin Powder for Oral Suspension
NAFDAC number
A4-3738
Active ingredient
Amoxicillin (Amoxicillin Trihydrate)
Strength
125 mg/5 mL
Form
Powder for suspension
Pack size
100 mL (in amber PET bottle)
Manufacturer
Not listed
Applicant (holder)
Tuyil Pharmaceutical Industries Ltd
Approved
28 Aug 2024
Status
Active View on NAFDAC ↗
Registration valid to
27 Aug 2029
WHO alerts
None found
Community reports
None
Times checked
0
Used to treat certain bacterial infections. General information only — antibiotics should only be used as prescribed by a doctor, and a full course should be completed.

What we found

  • Amoxicillin Powder for Oral Suspension is on the NAFDAC register with an active registration (A4-3738). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Amoxicillin Powder for Oral Suspension

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only), Streptococcus pneumoniae , Staphylococcus spp., or Haemophilus influenzae . Infections of the Genitourinary Tract: Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Escherichia coli, Proteus mirabilis , or Enterococcus faecalis . …

How to take it and how often
  • Adults, 750 to 1750 mg/day in divided doses every 8 to 12 hours
  • Pediatric Patients over 3 Months of Age, 20 to 45 mg/kg/day in divided doses every 8 to 12 hours
  • Refer to full prescribing information for specific dosing regimens
  • The upper dose for
  • Neonates and
  • Infants aged 3 months or younger is 30 mg/kg/day divided every 12 hours
  • Dosing for H. pylori Infection (in
  • Adults): Triple therapy: 1 gram amoxicillin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily (every 12 hours) for 14 days
  • Dual therapy: 1 gram amoxicillin and 30 mg lansoprazole, each given three times daily (every 8 hours) for 14 days
  • Reduce the dose in patients with severe renal impairment (GFR greater than 30 mL/min)
  • Important Administration Instructions To minimize the potential for gastrointestinal intolerance, amoxicillin tablets should be taken at the start of a meal
  • Dosage for
  • Adults and
  • Pediatric Patients Aged 3 Months (12 weeks) and Older Treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic, or evidence of bacterial eradication has been obtained
Strengths it comes in

500 mg Tablets are pink colored, capsule shaped, film coated tablets debossed with “A” on one side and “66” on the other side. 875 mg Tablets are pink colored, capsule shaped, film coated tablets debossed with “A” on one side and with a score line in between “6” and “7” on the other side. Tablets: 500 mg and 875 mg (3)

Children
  • The safety and effectiveness of amoxicillin
  • For the treatment of upper respiratory tract infections, and infections of the genitourinary tract, skin and skin structure and lower respiratory tract have been established
  • Pediatric patients
  • The safety and effectiveness of amoxicillin
  • For the treatment of H.Pylori infection have not been established
  • Pediatric patients
  • Because of incompletely developed renal function in
  • Neonates and young
  • Infants, the elimination of amoxicillin may be delayed. …
Older adults

An analysis of clinical studies of amoxicillin was conducted to determine whether subjects aged 65 and over respond differently from younger subjects. These analyses have not identified differences in responses between the elderly and younger patients, but a greater sensitivity of some older individuals cannot be ruled out. …

While you are taking it
  • Administration Instructions Advise patients that amoxicillin tablets may be taken every 8 hours or every 12 hours, depending on the dose prescribed
  • Allergic Reactions Counsel patients that amoxicillin tablets contains a penicillin class drug product that can cause allergic reactions in some individuals
  • Severe Cutaneous Adverse Reactions (SCAR) Advise patients about the signs and symptoms of serious skin manifestations
  • Instruct patients to stop taking amoxicillin tablets immediately and promptly report the first signs or symptoms of skin rash, mucosal lesions, or any other sign of hypersensitivity [see Warnings and Precautions ] . …
Talk to a doctor first if
  • Amoxicillin tablets are contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin tablets or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins)
  • History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin tablets or to other beta-lactams (e.g., penicillins or cephalosporins)
Medicines it may not mix with

Co-administration with probenicid is not recommended. (7.1) Concomitant use of amoxicillin and oral anticoagulants may increase the prolongation of prothrombin time. (7.2) Co-administration with allopurinol increases the risk of rash. (7.3) Amoxicillin may reduce the efficacy of oral contraceptives. (7.4) 7.1 Probenecid Probenecid decreases the renal tubular secretion of amoxicillin. Concurrent use of amoxicillin and probenecid may result in increased and prolonged blood levels of amoxicillin. 7.2 Oral Anticoagulants Abnormal prolongation of prothrombin time (increased international normalized ratio [INR]) has been reported in patients receiving amoxicillin and oral anticoagulants. …

Warnings

Anaphylactic reactions: Serious and occasionally fatal anaphylactic reactions have been reported in patients on penicillin therapy, including amoxicillin. Discontinue amoxicillin if a reaction occurs ( 5.1 ). Severe cutaneous adverse reactions (SCAR): Monitor closely. Discontinue if rash progresses. ( 5.2 ) Clostridioides difficile -associated diarrhea (CDAD) (ranging from mild diarrhea to fatal colitis): Evaluate if diarrhea occurs. ( 5.3 ) 5.1 Anaphylactic Reactions Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on penicillin therapy including amoxicillin. …

Possible side effects

The following are discussed in more detail in other sections of the labeling: Anaphylactic reactions [see Warnings and Precautions (5.1) ] Severe Cutaneous Adverse Reactions [see Warnings and Precautions (5.2) ] Clostridioides difficile- Associated Diarrhea (CDAD) [see Warnings and Precautions (5.3) ] The most common adverse reactions (greater than 1%) observed in clinical trials of amoxicillin tablets or for oral suspension were diarrhea, rash, vomiting, and nausea. (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . …

Pregnancy and breastfeeding

8.1 Pregnancy Teratogenic Effects : Pregnancy Category B. Reproduction studies have been performed in mice and rats at doses up to 2000 mg/kg (3 and 6 times the 3 g human dose, based on body surface area). There was no evidence of harm to the fetus due to amoxicillin. There are, however, no adequate and well-controlled studies in pregnant women. …

If you take too much

In case of overdosage, discontinue amoxicillin, treat symptomatically, and institute supportive measures as required. A prospective study of 51 pediatric patients at a poison-control center suggested that overdosages of less than 250 mg/kg of amoxicillin are not associated with significant clinical symptoms. Interstitial nephritis resulting in oliguric renal failure has been reported in a small number of patients after overdosage with amoxicillin 1 . Crystalluria, in some cases leading to renal failure, has also been reported after amoxicillin overdosage in adult and pediatric patients. …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2023-12-18.

Label for amoxicillin (amoxicillin trihydrate), the active ingredient registered with NAFDAC.

NAFDAC recall & alert notices

Public Alert No. 35/2025 – Substandard batches of Annmox (Amoxicillin suspensions 125mg/5ml) and Jawamox (Amoxicillin suspension 125mg/5ml) manufactured by Jawa International Ltd due to low Active Pharmaceutical Ingredient (API) content22 Oct 2025 · nafdac.gov.ngThe National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the mop up of batches of confirmed substandard Annmox (Batch 360M) and Jawamox (Batch 4231M & 4290M) Suspensions.The products failed laboratory analysis due to low Active Pharmaceutical Ingredient (API) content.The …Public Alert No. 34/2025 –Substandard Astamocil (Amoxicillin Suspension 125mg/5ml), Batch No. 826024, and Astamentin (Amoxicillin/Clavulanic Acid Suspension), Batch Nos: 0503024 & 0501724, manufactured by Sam-Ace Ltd in Nigeria22 Oct 2025 · nafdac.gov.ngThe National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public about the recall of two products: Astamocil (Amoxicillin Suspension 125mg/5ml), Batch 826024, and Astamentin (Amoxicillin/Clavulanic Acid Suspension 228.5 mg), Batches 0503024 and 0501724, manufactured by Sam-Ace Ltd in Ni…Public Alert No. 024/2025 – Recall of Amoxivue (Amoxicillin) 500mg Capsules due to significantly low Active Pharmaceutical Ingredient (API) content6 Aug 2025 · nafdac.gov.ngThe National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the recall of Amoxivue (Amoxicillin) 500mg, with NAFDAC NO: A4-100178 and Batch NO: 322584, manufactured by Sparsh Bio-Tech Pvt, Ltd.Note: Sparsh Bio-Tech has declared no relationship with the MAH- MedVue Pharmaceutic…

Compare the brands and batch numbers in these notices with your pack, or enter your batch number above.

Check your pack of Amoxicillin Powder for Oral Suspension

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC · WHO · U.S. FDA · Health Canada · NLM

About Amoxicillin Powder for Oral Suspension

What is in Amoxicillin Powder for Oral Suspension?

Amoxicillin Powder for Oral Suspension contains Amoxicillin (Amoxicillin Trihydrate) (125 mg/5 mL), as powder for suspension, according to its NAFDAC registration record.

Is Amoxicillin Powder for Oral Suspension registered with NAFDAC?

Yes. Amoxicillin Powder for Oral Suspension is listed on the NAFDAC register under registration number A4-3738, and its registration is active as of 28 October 2026.

Has Amoxicillin Powder for Oral Suspension been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Amoxicillin Powder for Oral Suspension in our automatically synced alert list.

How can I check that my pack of Amoxicillin Powder for Oral Suspension is genuine?

Run a free authenticity scan with the NAFDAC number A4-3738, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Amoxicillin Powder for Oral Suspension?

Follow your prescription or the leaflet in your pack. The official label says: In Adults, 750 to 1750 mg/day in divided doses every 8 to 12 hours. In Pediatric Patients over 3 Months of Age, 20 to 45 mg/kg/day in divided doses every 8 to 12 hours. Refer to full prescribing information for specific dosing regimens. ( 2.2 , 2.3 ) The upper dose for neonates and infants aged 3 months or younger is 30 mg/kg/day divided every 12 hours. ( 2.3 ) Dosing for H. py…

What is Amoxicillin Powder for Oral Suspension used for?

Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only), Streptococcus pneumoniae , Staphylococcus spp., or Haemophilus influenzae . Infections of the Genitourinary Tract: Amoxici (Summarised from the official U.S. FDA label for amoxicillin (amoxicillin trihydrate). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Amoxicillin Powder for Oral Suspension? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.